Concord Medical Co., Ltd. (TPEX:6518)

Concord Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	109.75	111.26	246.91	198.8	59.42
Short-Term Investments	211.5	209	100	-	-
Cash & Short-Term Investments	321.25	320.26	346.91	198.8	59.42
Cash Growth	0.31%	-7.68%	74.50%	234.55%	-22.56%
Accounts Receivable	301.6	306.75	314.22	310.82	311.53
Other Receivables	0.56	3.13	7.62	9.6	1.55
Receivables	302.15	309.88	321.85	320.42	313.08
Inventory	3.98	2.56	6.19	9.37	2.85
Prepaid Expenses	3.61	5.64	3.21	2.93	-
Other Current Assets	-	-	-	2.77	22.03
Total Current Assets	631	638.34	678.17	534.29	397.38
Property, Plant & Equipment	149.82	136.64	117.75	526.83	635.5
Long-Term Investments	20	-	-	-	-
Other Intangible Assets	2.65	2.63	1.95	1.76	29.27
Long-Term Accounts Receivable	3.34	4.63	0.96	-	-
Long-Term Deferred Tax Assets	0.26	0.29	0.54	0.4	0.76
Other Long-Term Assets	356.74	369.13	375.84	18.73	16.54
Total Assets	1,164	1,152	1,176	1,083	1,089
Accounts Payable	235.04	230.72	245.86	228.03	227.36
Accrued Expenses	0.37	0.28	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	11.54
Current Portion of Leases	25.41	23.05	20.49	18.48	19.89
Current Income Taxes Payable	7.43	4.68	9.74	5.52	2.08
Current Unearned Revenue	-	0.04	2.21	0.04	0.13
Other Current Liabilities	17.28	23.78	20.43	16.7	21.24
Total Current Liabilities	285.53	282.54	298.72	268.77	282.23
Long-Term Debt	35	35	-	-	89.56
Long-Term Leases	141.46	148.63	160.43	171.68	198.3
Other Long-Term Liabilities	4.54	4.54	4.91	4.8	5.33
Total Liabilities	466.53	470.71	464.06	445.25	575.42
Common Stock	333.33	333.33	333.33	333.33	250
Additional Paid-In Capital	179.22	179.22	179.22	179.22	162.55
Retained Earnings	184.71	169.23	159.82	125.83	101.43
Comprehensive Income & Other	-	-0.75	-0.75	-0.75	-0.75
Total Common Equity	697.26	681.03	671.62	637.63	513.23
Minority Interest	-	-	39.98	-	-
Shareholders' Equity	697.26	681.03	711.6	637.63	513.23
Total Liabilities & Equity	1,164	1,152	1,176	1,083	1,089
Total Debt	201.87	206.68	180.92	190.16	319.28
Net Cash (Debt)	119.37	113.58	165.99	8.64	-259.86
Net Cash Growth	5.10%	-31.57%	1822.12%	-	-
Net Cash Per Share	3.57	3.40	4.97	0.34	-10.37
Filing Date Shares Outstanding	33.33	33.33	33.33	33.33	25
Total Common Shares Outstanding	33.33	33.33	33.33	33.33	25
Working Capital	345.47	355.8	379.45	265.52	115.15
Book Value Per Share	20.92	20.43	20.15	19.13	20.53
Tangible Book Value	694.62	678.39	669.67	635.86	483.96
Tangible Book Value Per Share	20.84	20.35	20.09	19.08	19.36
Land	-	-	-	169.14	169.14
Buildings	-	-	-	49.02	49.02
Machinery	284.31	237.56	205.29	273.95	306.84
Construction In Progress	1.38	3.6	2.71	0.96	6.78
Leasehold Improvements	48.32	55.47	73.3	86.73	156.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.